Amgen To Present At The 2021 Jefferies Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Broadcom rises 3% on OpenAI custom "Jalapeño" chip reveal
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Amgen (AMGN) PT Raised to $272 at Oppenheimer
June 1, 2021 3:29 PM EDTOppenheimer analyst Jay Olson raised the price target on Amgen (NASDAQ: AMGN) to $272.00 (from $270.00) while maintaining an Outperform rating.
The analyst commented, "AMGN announced FDA approval of Lumakras ~2.5 months ahead of the 8/16 PDUFA. The approval marks the first KRAS G12C... More
